Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Literature
1.
2.
Pories WJ, The IDF Statement: a big and long-awaited step for our diabetic patients. Obes Surg. 2011;21:1487–9.PubMedCrossRef
3.
Dixon JB, Zimmet P, Alberti KG, et al. IDF Taskforce. Bariatric surgery: an IDF statement for obese type 2 diabetes. Surg Obes Relat Dis. 2011;7:433–47.PubMedCrossRef
4.
Sanderson I, Deitel M, Bojm MA. et al. The handling of glucose and insulin response before and after weight loss with jejuno-ileal bypass. JPEN J Parenter Enteral Nutr. 1983;7:274–6.PubMedCrossRef
5.
Deitel M, Sidhu PS, Stone E. Effect of vertical banded gastroplasty on diabetes in the morbidly obese. Obes Surg. 1991;1:113–4. abst.
6.
Scopinaro N, Adami GF, Papadia FS, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): a prospective controlled study. Obes Surg. 2011;21:880–8.PubMedCrossRef
7.
Deitel M. Update: why diabetes does not resolve in some patients after bariatric surgery. Obes Surg. 2011;21:794–6.PubMedCrossRef
8.
Deitel M. Considerations in adult onset type 1 diabetes (versus type 2). In: Deitel M, Gagner M, Dixon JB, Himpens J, Madan AK, editors. Handbook of Obesity Surgery. Toronto: FD-Communications; 2010. p. 316–9.
9.
Lee W-J, Chong K, Chen C-Y, et al. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. Obes Surg. 2011;21:889–95.PubMedCrossRef
10.
Boza C, Munoz R, Salinas J, et al. Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obes Surg. 2011;21:1330–6.PubMedCrossRef
11.
Abbatini F, Capoccia D, Casella G, et al. Type 2 diabetes in obese patients with body mass index of 30–35 kg/m(2): sleeve gastrectomy versus medical treatment. Surg Obes Relat Dis; 2011 (in press)
12.
Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m2. Surg Obes Relat Dis. 2010;6:332–9.PubMedCrossRef
Metadata
Title
A Comment on the International Diabetic Federation Statement
Author
Mervyn Deitel
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 1/2012
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-011-0553-4

Other articles of this Issue 1/2012

Obesity Surgery 1/2012 Go to the issue

Physiology Research

Sexual Dimorphism in Clock Genes Expression in Human Adipose Tissue

Clinical Research

Preoperative Predictors of Weight Loss Following Bariatric Surgery: Systematic Review

Clinical Research

Reducing Cost of Surgery by Avoiding Complications: the Model of Robotic Roux-en-Y Gastric Bypass

Clinical Research

Evaluating the Safety and Efficacy of BMI-Based Preoperative Administration of Low-Molecular-Weight Heparin in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass Surgery

Animal Research

Carbohydrate Content of Post-operative Diet Influences the Effect of Vertical Sleeve Gastrectomy on Body Weight Reduction in Obese Rats

Clinical Research

Reinforcing the Staple Line During Laparoscopic Sleeve Gastrectomy: Prospective Randomized Clinical Study Comparing Two Different Techniques. Preliminary results